NCT04685707

Brief Summary

Exercise has been shown to offer numerous health benefits and be particularly important in preventing weight gain or regain for people with obesity. Exercise guidelines can be difficult to interpret and apply independently and do not address specific exercise limitations in individuals with obesity. The exercise monitoring system proposed in this study might provide a new method to meet aerobic exercise guidelines independently with reduced risk of injury. The exercise monitoring system controls, in real-time, the intensity of an exercise session consisting of treadmill walking. During treadmill walking, the exercise monitoring system will instruct participants to increase or decrease how much participants raise their knees and swing their arms while maintaining a smooth contact with the ground, based on real-time readings of the participants' heart rate. In this clinical trial, each participant will perform a control and an experimental training session. Both training sessions will include four blocks of 7 minutes of treadmill walking alternated with three periods of rest (3 min). In the control session, participants will monitor the intensity of exercise independently using a standard heart rate monitor and control it by adjusting their walking speed. In the experimental session, each participant will follow the exercise monitoring system instructions displayed on a TV, and treadmill walking speed will be set at a comfortable walking speed. Target heart rates of 60% HRR will be used as the exercise intensities in both training sessions. The investigators will examine energy expenditure, heart rate, and kinematic measures under control and experimental conditions. The goals of this clinical trial are to determine the effect of exercising with the exercise monitoring system in individuals with obesity. The investigators hypothesized that the experimental session will result in higher total energy cost and efficiency than the control session; and in lower heart rate error, tibial positive peak accelerations and feedback errors than the control session. The results of this study will inform proposals for larger interventions that will focus on 1) testing different types of obesity and osteoarthritis, 2) adding a resistance-training component, and 3) integrating a diet intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable obesity

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 10, 2020

Completed
18 days until next milestone

First Posted

Study publicly available on registry

December 28, 2020

Completed
8 months until next milestone

Study Start

First participant enrolled

September 1, 2021

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2023

Completed
10 months until next milestone

Results Posted

Study results publicly available

September 23, 2024

Completed
Last Updated

September 23, 2024

Status Verified

May 1, 2024

Enrollment Period

1.2 years

First QC Date

December 10, 2020

Results QC Date

August 29, 2023

Last Update Submit

May 17, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Energy Expenditure (Oxygen Consumption)

    Energy expenditure was evaluated from oxygen consumption (ml/kg/min) measured during the exercise and recovery bouts using a breath-by-breath portable metabolic analyzer (K5, COSMED, Rome, Italy).

    1 Day

  • Heart Rate (Bpm)

    Average heart rate (bpm) during steady state period of exercise.

    1 day

  • Percentage of Strides With Tibia Peak Positive Accelerations Above 3g

    1 day

Secondary Outcomes (2)

  • Mean Tibial Positive Peak Acceleration

    Up to 4 weeks

  • Heart Rate Error

    1 day

Study Arms (2)

HFFS, then Control

EXPERIMENTAL

Participants first performed the HFFS (increased hip flexion) exercise session. After a washout period of at least 24h, they then performed the Control (walking/running) exercise session.

Device: Visual feedback monitoring system (HFFS)Other: Control

Control, then HFFS

EXPERIMENTAL

Participants first performed the Control (walking/running) exercise session. After a washout period of at least 24h, they then performed the HFFS (increased hip flexion) exercise session.

Device: Visual feedback monitoring system (HFFS)Other: Control

Interventions

Participants will follow the exercise monitoring system's instructions displayed on a TV. Treadmill walking speed will be set at a comfortable walking speed.

Control, then HFFSHFFS, then Control
ControlOTHER

Participants will monitor the intensity of exercise independently using a standard heart rate monitor and control it by adjusting the treadmill speed (walking speed).

Control, then HFFSHFFS, then Control

Eligibility Criteria

Age20 Years - 45 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • BMI ≥ 30.0 kg/m2 and ≤ 40.0 kg/m2
  • Age 20 to 45 years;
  • Able to understand spoken English at the level needed to:
  • understand and follow instructions for equipment setup, testing, and task performance
  • answer questions related to effort and preference
  • be able to understand consent document and provide informed assent

You may not qualify if:

  • Any signs or symptoms suggestive of cardiovascular, pulmonary, metabolic, or renal disease.
  • Any injury or health condition that affects the ability to walk on a treadmill.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Southern Mississippi

Hattiesburg, Mississippi, 39402, United States

Location

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Dr. Nuno Oliveira
Organization
University of Southern Mississippi

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2020

First Posted

December 28, 2020

Study Start

September 1, 2021

Primary Completion

November 30, 2022

Study Completion

November 30, 2023

Last Updated

September 23, 2024

Results First Posted

September 23, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations